China Resources Pharmaceutical Group Limited (HKG:3320)

HKG:3320 Statistics

Total Valuation

HKG:3320 has a market cap or net worth of HKD 31.22 billion. The enterprise value is 160.54 billion.

Market Cap	31.22B
Enterprise Value	160.54B

Important Dates

The last earnings date was Monday, August 25, 2025.

Earnings Date	Aug 25, 2025
Ex-Dividend Date	Sep 11, 2025

Share Statistics

HKG:3320 has 6.28 billion shares outstanding.

Current Share Class	6.28B
Shares Outstanding	6.28B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	6.60%
Float	1.83B

Valuation Ratios

The trailing PE ratio is 10.18 and the forward PE ratio is 7.40. HKG:3320's PEG ratio is 1.14.

PE Ratio	10.18
Forward PE	7.40
PS Ratio	0.11
PB Ratio	0.25
P/TBV Ratio	1.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.14

Enterprise Valuation

EV / Earnings	52.33
EV / Sales	0.56
EV / EBITDA	9.94
EV / EBIT	12.16
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.74.

Current Ratio	1.41
Quick Ratio	1.02
Debt / Equity	0.74
Debt / EBITDA	5.73
Debt / FCF	n/a
Interest Coverage	5.63

Financial Efficiency

Return on equity (ROE) is 7.57% and return on invested capital (ROIC) is 3.99%.

Return on Equity (ROE)	7.57%
Return on Assets (ROA)	2.66%
Return on Invested Capital (ROIC)	3.99%
Return on Capital Employed (ROCE)	8.25%
Revenue Per Employee	3.32M
Profits Per Employee	35,674
Employee Count	72,700
Asset Turnover	0.94
Inventory Turnover	5.57

Taxes

In the past 12 months, HKG:3320 has paid 2.61 billion in taxes.

Income Tax	2.61B
Effective Tax Rate	23.14%

Stock Price Statistics

The stock price has increased by +1.24% in the last 52 weeks. The beta is 0.09, so HKG:3320's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	+1.24%
50-Day Moving Average	5.21
200-Day Moving Average	5.23
Relative Strength Index (RSI)	38.35
Average Volume (20 Days)	19,607,262

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:3320 had revenue of HKD 285.94 billion and earned 3.07 billion in profits. Earnings per share was 0.49.

Revenue	285.94B
Gross Profit	45.22B
Operating Income	12.89B
Pretax Income	11.29B
Net Income	3.07B
EBITDA	15.83B
EBIT	12.89B
Earnings Per Share (EPS)	0.49

Balance Sheet

The company has 29.37 billion in cash and 90.68 billion in debt, giving a net cash position of -61.30 billion or -9.76 per share.

Cash & Cash Equivalents	29.37B
Total Debt	90.68B
Net Cash	-61.30B
Net Cash Per Share	-9.76
Equity (Book Value)	122.77B
Book Value Per Share	8.72
Working Capital	64.37B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 15.81%, with operating and profit margins of 4.51% and 1.08%.

Gross Margin	15.81%
Operating Margin	4.51%
Pretax Margin	3.95%
Profit Margin	1.08%
EBITDA Margin	5.54%
EBIT Margin	4.51%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 2.28%.

Dividend Per Share	0.11
Dividend Yield	2.28%
Dividend Growth (YoY)	-48.21%
Years of Dividend Growth	4
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	2.28%
Earnings Yield	9.83%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4